Daloopa Raises $47M to Make AI-Driven Investment Research Reliable and Auditable – AlleyWatchJune 2, 2026
Alnylam amyloidosis drug led to “small” benefits: FDA Markets September 11, 2023 Grandbrothers The U.S. Meals and Drug Administration (FDA) mentioned Monday that patisiran, a RNAi therapeutic developed by Alnylam Prescribed drugs…
